🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Removal

According to TikTok, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or administering at home.

Within minutes of joining one community, a vendor posted contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these communities, posts show black plastic parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially significant health risks”.